Shanghai Pharmaceuticals (02607) Announces February Share Capital Update

Bulletin Express03-02 17:49

Shanghai Pharmaceuticals Holding Co., Ltd. (Stock Code: 02607) released its monthly return for the period ended 28 February 2026. The H-share capital remained at 919.07 million shares, with no increase or decrease from the preceding month. The A-share capital, not listed on the Hong Kong Stock Exchange, remained at 2.79 billion shares, leading to total authorized share capital of 3.71 billion shares.

No new shares were issued or canceled during February, and there were no treasury share movements reported. The outstanding A-share options stood at 680,000 with an exercise price of RMB 20.16, with no exercise activity recorded. According to the report, the company confirmed compliance with its public float requirements for its H shares, affirming a public float threshold of 5.00%. All relevant confirmations have been provided as part of the filing, and no other share issuances were disclosed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment